Novavax had been hoping to find a sizable sales opportunity by advancing a protein-based alternative to the messenger RNA ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

The options include the mRNA vaccines from Pfizer/BioNTech and Moderna — the vaccines that the vast majority of Americans ...

Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s ...

Health professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. The findings will be presented by ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

COVID-19 vaccine DNA contamination claims aren't new, but have resurfaced in the wake of a Canadian study that some ...

Anyone with COVID-19 during the summer has some, but not full, protection against germs spreading in fall and winter.

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics discovery, and Fina Biosolutions LLC (FinaBio), experts in ...